{
    "title": "Merck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11452605/Drugmaker-Merck-acquire-Imago-BioSciences-1-35-bln.html",
    "date": "2022-11-21",
    "keywords": [
        "drug",
        "imago",
        "blood",
        "offer",
        "company",
        "deal",
        "mahobe",
        "inc",
        "cancer",
        "portfolio",
        "keytruda",
        "revenue",
        "loss",
        "gap",
        "seigerman",
        "monday",
        "developer",
        "equity",
        "value",
        "disorder",
        "share",
        "cash",
        "premium",
        "companys",
        "trading",
        "blockbuster",
        "immunotherapy",
        "year",
        "pharma",
        "access",
        "therapy",
        "type",
        "pressure",
        "merck",
        "biotech",
        "seagen",
        "summer",
        "potential",
        "exclusivity",
        "decade",
        "capital",
        "analyst",
        "patent",
        "treatment",
        "bone",
        "bomedemstat",
        "midstage",
        "effect",
        "term",
        "tender",
        "unit",
        "completion",
        "transaction",
        "quarter",
        "reporting",
        "raghav",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}